Add Yahoo as a preferred source to see more of our stories on Google. Asthma treatment may be affected by the time you take your inhaler, scientists suggest. Christin Klose/dpa-tmn A mid-afternoon ...
Patients with severe asthma which is not controlled with standard treatment—leaving them at risk of severe asthma attacks—could benefit from using a single inhaler combining three, instead of two ...
A single daily preventer dose of inhaled corticosteroid (beclomethasone), taken at mid-afternoon, may be the best timing for effective asthma control as it suppresses the usual nocturnal worsening of ...
This reminder follows updates to product information and the National Institute for Health and Care Excellence (NICE) guidance for short-acting beta 2 agonists (SABAs), including salbutamol and ...
Breathing techniques can cut the use of reliever inhalers by more than 80% and halve the dose of preventer inhaler required in mild asthma, finds research published ahead of print in Thorax. The ...
Folks with asthma might better control their symptoms by precisely timing when they use their inhaler, a new study says. A single daily preventive dose of inhaled corticosteroid is best taken at ...
A new study is probing why asthma relief inhalers might actually make asthma worse -- and what can be done about it. A new study at the University of Leicester is probing why asthma relief inhalers ...
Inhalers that combine providing immediate relief with a longer-term preventative effect are already recommended as the standard treatment for mild asthma among people aged 12 and above in the UK, US ...
LONDON -- Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a study has revealed. Researchers found that over-use of short acting ...
Asthma is an extremely common chronic condition that can be triggered and exacerbated by the stress of visiting the dentist. When someone is having an asthma attack, their airways go into spasm which ...
A new 3-in-1 asthma drug inhaler may provide better and easier control of symptoms for tough-to-treat patients, two new studies suggest. The two phase 3 trials involved more than 2,500 asthma patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results